Navigation Links
EMRs Put to the Test on Usability
Date:4/7/2009

nce, and experts in user interface design," says Dr. Robert Schumacher, Managing Director. "For the first time health care purchasers will get to the heart of 'meaningful use' - objective, independent data based on actual use. Our research will not be based on a surveys or checklists. It is real performance measurement gathered from practicing clinicians using realistic data. Combined with CCHIT and KLAS data, health-care purchasers can have a complete picture of function, opinion, and now usability of applications."

User Centric's syndicated research offering consists of employing state-of-the-art user research methods to measure efficiency, effectiveness, and satisfaction. Clinical users, representative of the market, will perform tasks based on use cases drawn from ONCHIT. Criterion-based measures of learnability and usability will be collected.

Usability is highly correlated with adoption. Applications that are more usable stand a higher chance of success in the marketplace.

The service is fee-based to offset costs, and all subscribing vendors will receive an extensive report on the user performance of their application. In our initial offering, the first ten subscribing vendors will receive the report, and a readout as well as expert advice on how to improve the customer experience with user interface. Health Care Organizations can have access to the report in late 2nd quarter.

The research will be run regularly and be made available to consultants and providers. Set for delivery before ONCHIT provides guidance in the Fall of 2009, solutions providers can opt in to the study before May 15, 2009.

To find out how to have your EMR part of the study and costs involved, contact Gavin Lew or Robert Schumacher at +1.630.320.3900. Further syndicated studies are envisioned in other areas of health IT in the coming months. Visit User Centric at HIMSS 2009 (

SOURCE User Centric, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. User Centric Offers New Service, Usability Diagnostics, to Measure HIT Usability
2. User Centric to Address EHR Usability With New Service Offering
3. Human Factors International Sponsors Usability Professionals Association (UPA) 2008 International Conference
4. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales Representatives ... Los Cabos, Mexico, Feb. 23-March 1, 2013, to help renovate ... The facility serves meals and provides a social outlet for ... , Platinum Vice President, Mike Muench, says that the idea ... , “Platinum got its start selling long-term care insurance ...
(Date:5/21/2013)... May 21, 2013 Dimensional Insight, a ... announced that Western Maryland Health System, a ... The Diver Solution™ (Diver) to help it analyze its ... first customer to purchase Diver through Dimensional Insight’s recently ... Like most hospitals, Western Maryland has massive amounts of ...
(Date:5/21/2013)... Tools4ever, the market leader in Identity & Access ... Password Management (SSRPM) suitable for BYOD. With the latest ... on mobile systems i.e.; laptops, tablets, handheld computers and ... Windows passwords anywhere, anytime. Once the end user has ... then reset his or her own password. , ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Thousands of ... from the lung condition known as chronic obstructive ... that patients placed on the common antibiotic azithromycin ... due to flare-ups of the disease. "Given ... of such events is critical," said Victoria Richards, ...
(Date:5/21/2013)... ─ Clinical measurement of physical activity appears to ... patients with chronic obstructive pulmonary disease (COPD) will ... study conducted by researchers in Connecticut. The study ... levels of inactivity with an increased incidence of ... of the study will be presented at the ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3Health News:Tools4ever’s password reset software ready for BYOD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 3Health News:Exercise levels may predict hospitalizations in COPD population 2
... Dec. 13, Speaker Nancy Pelosi,issued the following statement ... Leader George Mitchell, which found widespread use,of steroids and ... Mitchell Report tells a troubling story of how many ... the fans of our national,pastime by using steroids and ...
... Poll Shows Rural Seniors Want E-Prescribing in Medicare, ... so many issues, promoting electronic prescribing (e-prescribing) in,Medicare ... and Democrats can,agree on. "The Medicare Electronic Medication ... require that Medicare physicians begin to,prescribe electronically, will ...
... The University of Illinois at Chicago College of Nursing has ... people as they transition to the end of life. ... the science of care for people of all ages facing ... funded through a $2.4 million grant from the National Institute ...
... side effects, including heart trouble , , THURSDAY, Dec. 13 ... Andy Pettitte, Houston Astros All-Star shortstop Miguel Tejada and ... players cited in a highly anticipated report into the ... , The report climaxed a 20-month probe by former ...
... 13 The Quantum Group,Inc. (Amex: QGP, QGP.U) ... its registered public offering, raising $13.2 million in,gross ... initiated trading,on the American Stock Exchange (AMEX) of ... "QGP.U." In addition, Quantum common shares,formerly traded on ...
... Dec. 13 Repligen Corporation,(Nasdaq: RGEN ) ... has been,elected to its Board of Directors. Dr. ... and regulatory expertise in the,development of therapeutics for ... very pleased to welcome an executive with Earl,s ...
Cached Medicine News:Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 2Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 3Health News:New UIC center to study end-of-life transition 2Health News:New UIC center to study end-of-life transition 3Health News:Report Finds 'Widespread Steroid Use in Baseball' 2Health News:Report Finds 'Widespread Steroid Use in Baseball' 3Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 2Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 3Health News:Repligen Elects Earl Henry, M.D. to the Board of Directors 2Health News:Repligen Elects Earl Henry, M.D. to the Board of Directors 3
(Date:5/21/2013)... 2013  Lehigh Valley Health Network has announced the ... adding to its existing arsenal of five 5-foot-5 germ-killing ... within the network, LVHN is now deploying the largest ... superbugs and provide the best possible patient care available. ... TRU-D – the signature product of Memphis ...
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... , May 21, 2013  BioRestorative Therapies, Inc. ... sciences company focused on developing stem cell based therapies ... Weinreb , its President and CEO, will be ... The conference will be held on Thursday, May 30, ... E 42nd Street in New York City.  Mr. Weinreb,s ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
... , , , ... academic, private and government cancer drug discovery efforts , ... Research Institute today announced that it has been selected as ... Institute,s (NCI) Chemical Biology Consortium (CBC)--a program meant to coordinate ...
... , , , ... N.J., Aug. 19 Newly published data in The New ... (letrozole tablets) following surgery as an optimal treatment approach versus tamoxifen ... , The data include an analysis from the ...
Cached Medicine Technology:Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 2Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 3Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 4Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 2Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 3Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 4Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 5Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 6Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 7Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 8Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 9
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
... for small and medium volume laboratories, as ... System offers the speed, simplicity and flexibility ... Compact yet powerful, the Elecsys 1010 system ... response assays to routine testing without sacrificing ...
Sample throughput of up to 80 tests per hour (4 modules). Low maintenance requirements. Continuous random access. 25 - 100 channels on board. 1008 tests or 6 hours of walkaway operation....
Medicine Products: